This episode is part of ACC’s ongoing effort to advance understanding of inflammation and its role in cardiovascular risk assessment. Drs. Antonio Abbate and Brittany Weber discuss the clinical relevance of high-sensitivity C-reactive protein (hs-CRP), including what it measures, which patients should be considered for testing, and how results can help refine cardiovascular risk discussions beyond traditional risk factors. Through a practical, case-based conversation, they explore how hs-CRP can be incorporated into screening, prevention, and management strategies for patients with or at risk for cardiovascular disease.

This podcast is part of the ACC’s hs-CRP educational initiative, supported by Novo Nordisk. The program provides educational resources to help clinicians interpret inflammatory risk and apply hs-CRP findings to cardiovascular risk assessment, screening, and management decisions. Click here to learn more.